Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;15(4):279-84.
doi: 10.5812/ircmj.6499. Epub 2013 Apr 5.

Prostate cancer: current treatment and prevention strategies

Affiliations
Review

Prostate cancer: current treatment and prevention strategies

Fang-Zhi Chen et al. Iran Red Crescent Med J. 2013 Apr.

Abstract

Prostate cancer is one of the life threatening disorders of male. Although, over the last two decades, a high rate of overdiagnosis, and overtreatment has lowered the incidence rate of prostate cancer, the treatment or prevention strategies are not enough to control the high rate of disease related mortality. Current medical treatment approaches include surgery, radiation therapy, chemotherapy, hormonal therapy, cryosurgery and other methods. These approaches are more or less effective either as monotherapy or in multimodal approach. However, many adverse or side effects exist with these strategies. Researches are ongoing to find out the way or better strategies to eliminate the adverse effects. Dietary modifications may also contribute to decrease prostate cancer risk. Several nutraceuticals against prostate cancer have also been identified. This review article summarizes some of the current treatment, and prevention strategies with the protection of prostate cancer, which may be helpful to control and prevent this highly frequent life threatening disease.

Keywords: Cryosurgery; Diet Therapy; Maintenance Chemotherapy; Prostate Cancer; Proton Therapy; Radiation Oncology; Radiotherapy.

PubMed Disclaimer

References

    1. Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006;42(15):2463–71. doi: 10.1016/j.ejca.2006.02.027. - DOI - PubMed
    1. Andriole GL, Crawford ED, Grubb RL, 3rd, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–9. doi: 10.1056/NEJMoa0810696. - DOI - PMC - PubMed
    1. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–8. doi: 10.1056/NEJMoa0810084. - DOI - PubMed
    1. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, et al. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302(11):1202–9. doi: 10.1001/jama.2009.1348. - DOI - PMC - PubMed
    1. Mongiat-Artus P, Peyromaure M, Richaud P, Droz JP, Rainfray M, Jeandel C, et al. [Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology]. Prog Urol. 2009;19(11):810–7. doi: 10.1016/j.purol.2009.02.008. - DOI - PubMed